Business Description
Unibios Holdings SA
ISIN : GRS084003011
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.33 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 1.41 | |||||
Interest Coverage | 4.76 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.8 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.1 | |||||
3-Year EBITDA Growth Rate | 58.5 | |||||
3-Year Book Growth Rate | 6.2 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 85.43 | |||||
9-Day RSI | 77.55 | |||||
14-Day RSI | 69.07 | |||||
6-1 Month Momentum % | 7.48 | |||||
12-1 Month Momentum % | 22.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.85 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 208.36 | |||||
Days Sales Outstanding | 133.79 | |||||
Days Payable | 51.94 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.3 | |||||
Shareholder Yield % | 14.16 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 39.05 | |||||
Operating Margin % | 14.87 | |||||
Net Margin % | 14.71 | |||||
FCF Margin % | -3.84 | |||||
ROE % | 13.04 | |||||
ROA % | 7.49 | |||||
ROIC % | 7.55 | |||||
ROC (Joel Greenblatt) % | 23.95 | |||||
ROCE % | 15.5 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.41 | |||||
PE Ratio without NRI | 12.6 | |||||
Price-to-Owner-Earnings | 14.68 | |||||
PEG Ratio | 1.33 | |||||
PS Ratio | 2.02 | |||||
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 2.71 | |||||
EV-to-EBIT | 10.48 | |||||
EV-to-EBITDA | 9.28 | |||||
EV-to-Revenue | 2.25 | |||||
EV-to-FCF | -58.68 | |||||
Price-to-Projected-FCF | 4.1 | |||||
Price-to-Median-PS-Value | 5.16 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.76 | |||||
Price-to-Graham-Number | 1.23 | |||||
Price-to-Net-Current-Asset-Value | 8.42 | |||||
Earnings Yield (Greenblatt) % | 9.54 | |||||
FCF Yield % | -1.9 | |||||
Forward Rate of Return (Yacktman) % | 3.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Unibios Holdings SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 13.594 | ||
EPS (TTM) (€) | 0.17 | ||
Beta | 1.12 | ||
Volatility % | 29.91 | ||
14-Day RSI | 69.07 | ||
14-Day ATR (€) | 0.054123 | ||
20-Day SMA (€) | 1.46875 | ||
12-1 Month Momentum % | 22.42 | ||
52-Week Range (€) | 1.08 - 1.85 | ||
Shares Outstanding (Mil) | 17.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Unibios Holdings SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Unibios Holdings SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Unibios Holdings SA Frequently Asked Questions
What is Unibios Holdings SA(ATH:BIOSK)'s stock price today?
When is next earnings date of Unibios Holdings SA(ATH:BIOSK)?
Does Unibios Holdings SA(ATH:BIOSK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |